Mallinckrodt PLC (MCKPF)
0.12
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Mallinckrodt Revenue (Quarterly): 514.30M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 514.30M |
March 31, 2024 | 467.80M |
September 30, 2023 | 497.00M |
June 30, 2023 | 475.00M |
March 31, 2023 | 424.60M |
December 31, 2022 | 489.30M |
September 30, 2022 | 550.40M |
June 30, 2022 | 383.70M |
March 31, 2022 | 490.90M |
December 31, 2021 | 597.20M |
September 30, 2021 | 507.20M |
June 30, 2021 | 546.40M |
March 31, 2021 | 558.00M |
December 31, 2020 | 682.80M |
September 30, 2020 | 698.30M |
June 30, 2020 | 166.50M |
March 31, 2020 | 665.80M |
December 31, 2019 | 804.90M |
September 30, 2019 | 743.70M |
June 30, 2019 | 823.30M |
March 31, 2019 | 790.60M |
December 31, 2018 | 834.90M |
September 30, 2018 | 799.90M |
June 30, 2018 | 825.50M |
Date | Value |
---|---|
March 31, 2018 | 755.30M |
December 31, 2017 | 1.461B |
September 30, 2017 | 600.60M |
June 30, 2017 | 824.50M |
March 31, 2017 | 810.90M |
December 31, 2016 | 829.90M |
September 30, 2016 | 577.40M |
June 30, 2016 | 970.60M |
March 31, 2016 | 918.00M |
December 31, 2015 | 811.20M |
September 30, 2015 | 459.50M |
June 30, 2015 | 877.30M |
March 31, 2015 | 819.00M |
December 31, 2014 | 768.20M |
September 30, 2014 | -100.80M |
June 30, 2014 | 653.10M |
March 31, 2014 | 557.80M |
December 31, 2013 | 540.20M |
September 30, 2013 | 53.00M |
June 30, 2013 | 570.00M |
March 31, 2013 | 585.30M |
December 31, 2012 | 504.00M |
September 30, 2012 | 513.10M |
June 30, 2012 | 516.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
166.50M
Minimum
Jun 2020
804.90M
Maximum
Dec 2019
540.20M
Average
514.30M
Median
Jun 2024
Revenue (Quarterly) Benchmarks
Alkermes PLC | 399.13M |
Jazz Pharmaceuticals PLC | 1.024B |
Medtronic PLC | 7.915B |
Perrigo Co PLC | 1.066B |
Iterum Therapeutics PLC | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -43.30M |
Total Expenses (Quarterly) | 476.40M |
EPS Diluted (Quarterly) | -2.20 |
Enterprise Value | 1.458B |
Gross Profit Margin (Quarterly) | 37.92% |
Profit Margin (Quarterly) | -8.42% |
Earnings Yield | -159.0K% |
Normalized Earnings Yield | -79219.34 |